The “King Kong” of Weight Loss Drugs May Upend Ozempic
The “King Kong” of Weight Loss Drugs May Upend Ozempic

The “King Kong” of Weight Loss Drugs May Upend Ozempic

Business Wars Daily

14.04.2023 • 4 Min.

Today is Friday, April 14, and we're looking at Novo Nordisk vs. Eli Lilly. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.